Correlation Engine 2.0
Clear Search sequence regions


  • allodynia (1)
  • anomalin (10)
  • ap 1 (2)
  • carrageenan (2)
  • chronic disease (1)
  • chronic pain (3)
  • coumarins (2)
  • CREB (3)
  • creb protein (1)
  • cyclic amp (2)
  • edema (1)
  • element (2)
  • gene (2)
  • hyperalgesia (4)
  • liver (1)
  • male (1)
  • MAPKs (3)
  • mice (3)
  • mitogen (3)
  • nervous system (1)
  • NF κB (5)
  • nitric oxide (2)
  • nitrite (3)
  • p (3)
  • pain (3)
  • plasma (2)
  • protein kinases (2)
  • signal (1)
  • time factors (1)
  • TNF α (1)
  • Tumor Necrosis Factor (2)
  • Sizes of these terms reflect their relevance to your search.

    The numerous mediators of pain and inflammation are products of injury-induced gene expression that lead to changes in the nervous system and immune responses. These multiple molecules and mechanisms suggest novel strategies that could be used for analgesic drug development. The present study investigated the possible anti-hyperalgesic effects of anomalin in complete Freund's adjuvant (CFA)-induced acute and chronic inflammatory pain models. Acute pretreatment of mice with anomalin (10 and 50mg/kg, i.p.) produced a significant anti-nociceptive effect against CFA- and carrageenan-induced mechanical hyperalgesia and allodynia. In a chronic pain model, administration of anomalin inhibited CFA-induced hyperalgesia, and it did not cause any apparent toxicity. Another set of experiments observed that anomalin inhibited CFA- and carrageenan-induced paw edema in acute and chronic models. To elucidate the molecular mechanism underlying the anti-nociceptive effect of anomalin, the various pain signaling pathways [NF-κB, cAMP response element-binding protein (CREB), and mitogen activated protein kinase (MAPKs)/AP-1] that are involved were examined. Intraperitoneal (i.p.) pretreatment of anomalin exhibited potent inhibitory effects on direct mediators of hyperalgesia (iNOS and COX-2). The release of CFA-induced plasma nitrite and paw tissue hyperalgesic cytokine (TNF-α) was reduced remarkably. In addition, the adenosine 5'-triphosphate (ATP) in plasma and substance P (SP) in paw tissue were markedly suppressed by anomalin. These results demonstrate that anomalin exhibits an analgesic effect in a consistent manner and that its mechanisms involve the inhibition of the NF-κB, CREB, and MAPKs/AP-1 signaling pathways. © 2013 Elsevier B.V. All rights reserved.

    Citation

    Salman Khan, Omer Shehzad, Jaemoo Chun, Yeong Shik Kim. Mechanism underlying anti-hyperalgesic and anti-allodynic properties of anomalin in both acute and chronic inflammatory pain models in mice through inhibition of NF-κB, MAPKs and CREB signaling cascades. European journal of pharmacology. 2013 Oct 15;718(1-3):448-58

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 23911882

    View Full Text